OPK
OPKO Health, Inc.Marquee-fund ownership over time
This quarter's activity
Current holders
Sorted by tenure (longest first)| Fund | First disclosed | Held | Entry price | Latest close | Return on entry |
|---|---|---|---|---|---|
| Renaissance Technologies re-entered | Q3 2024(8Q snapshot) | 7Q | $1.50 | $1.13 | -25% |
| Citadel Advisors | Q3 2024(8Q snapshot) | 7Q | $1.53 | $1.13 | -26% |
| AQR Capital Management | Q3 2024(8Q snapshot) | 7Q | $1.53 | $1.13 | -26% |
| Point72 Asset Management | Q2 2026(8Q snapshot) | 1Q | $1.10 | $1.13 | +3% |
“Return on entry” is the price-only move from the fund's first disclosure to today — it ignores any adds, trims, or dividends. A fund that built its position over multiple quarters has a true cost basis somewhere between entry price and latest close; this figure is the upper bound.
Past holders
Funds that exited at some point| Fund | Last entry | Exited | Entry → Exit | Return |
|---|---|---|---|---|
| Millennium Management 2× in & out | Q1 2026 | Q2 2026 | → $1.10 | -10% |
| Two Sigma Investments 2× in & out | Q2 2025 | Q3 2025 | — | +0% |
| D.E. Shaw | Q2 2025 | Q3 2025 | → $1.35 | +2% |
| Bridgewater Associates | Q4 2022 | Q2 2023 | → $1.72 | +8% |
| JANA Partners | Q4 2013 | Q2 2014 | → $8.18 | -19% |
Insider activity
Form 4 — officers, directors, 10%+ ownersFiled within two business days of each transaction by anyone with material insider status at OPKO HEALTH, INC.. Pair with the holders table above as a sanity check: heavy insider buying alongside marquee-fund accumulation is the strongest accumulation signal; heavy insider selling alongside fund exits is the strongest distribution signal.
30d / 90d windows measured from Mar 20, 2026 — the most recent Form 4 on file — not from today.
- Form 40001193125-26-117703Mar 20, 2026
- Form 40001193125-26-117673Mar 20, 2026
- Form 40001193125-25-291590Nov 21, 2025
- Form 40001193125-25-290115Nov 20, 2025
- Form 40001193125-25-288284Nov 19, 2025
- Form 40001193125-25-286448Nov 18, 2025
- Form 40001193125-25-260956Oct 31, 2025
- Form 40000950170-25-110094Aug 19, 2025
- Form 40000950170-25-105971Aug 8, 2025
- Form 40000950170-25-079123May 29, 2025
- Form 40000950170-25-079120May 29, 2025
- Form 40000950170-25-079115May 29, 2025
- Form 40000950170-25-079112May 29, 2025
- Form 40000950170-25-079109May 29, 2025
- Form 40000950170-25-079104May 29, 2025
Fundamentals
XBRL · OPKO Health, Inc.Annual figures sourced directly from OPKO Health, Inc.'s 10-K / 10-Q filings via SEC EDGAR XBRL. Latest fiscal year and the year-over-year change, with up to ten years of history.
Recent SEC filings
10-K · 10-Q · 8-K · 13D/G · proxyThe most recent material filings for OPKO HEALTH, INC. — earnings, material events, ownership disclosures, proxy statements. Form 4 insider activity is shown in the panel above.
- DEF 14AProxy statementApr 30, 2026
- 10-QQuarterly reportApr 28, 2026
- 8-KMaterial eventApr 28, 2026
- 8-KMaterial eventMar 19, 2026
- 10-KAnnual reportFeb 26, 2026
- 8-KMaterial eventFeb 26, 2026
- 10-QQuarterly reportOct 29, 2025
- 8-KMaterial eventOct 29, 2025
- 8-KMaterial eventSep 15, 2025
- 10-QQuarterly reportJul 31, 2025
- 8-KMaterial eventJul 31, 2025
- 8-KMaterial eventMay 29, 2025
- 10-QFORM 10-QMay 1, 2025
- 8-KFORM 8-KApr 30, 2025
- 8-KFORM 8-KApr 23, 2025
Trade history
Every open→close lifecycle across tracked funds| Fund | Open date | Close date | Open price | Close price / current | Return |
|---|---|---|---|---|---|
| Point72 Asset Management | Q2 2026 | open | $1.10 | $1.13 | +3% |
| Renaissance Technologies | Q2 2026 | open | $1.10 | $1.13 | +3% |
| Millennium Management | Q1 2026 | Q2 2026 | $1.22 | $1.10 | -10% |
| Renaissance Technologies | Q3 2025 | Q1 2026 | $1.35 | $1.21 | -10% |
| Two Sigma Investments | Q2 2025 | Q3 2025 | $0.00 | — | +0% |
| D.E. Shaw | Q2 2025 | Q3 2025 | $1.33 | $1.35 | +2% |
| Citadel Advisors | Q3 2024 | open | $1.53 | $1.13 | -26% |
| Two Sigma Investments | Q3 2024 | open | $1.53 | $1.13 | -26% |
| AQR Capital Management | Q3 2024 | open | $1.53 | $1.13 | -26% |
| Millennium Management | Q3 2024 | Q4 2025 | $1.53 | $1.28 | -16% |
| Renaissance Technologies | Q3 2024 | Q2 2025 | $1.50 | $1.26 | -16% |
| Bridgewater Associates | Q4 2022 | Q2 2023 | $1.60 | $1.72 | +8% |
| JANA Partners | Q4 2013 | Q2 2014 | $10 | $8.18 | -19% |
- Covers only the 27 marquee funds tracked here, not the full institutional universe. A “0 holders” reading does not mean unowned.
- Heavy funds (Renaissance Technologies, Citadel Advisors, Soros Fund Management, Two Sigma Investments, D.E. Shaw, AQR Capital Management, Millennium Management, Point72 Asset Management) use 8-quarter snapshots, so their pre-2024 history is missing.
- “Current” reflects each fund's most recent 13F — filings lag the actual trade by up to 45 days; positions shown may have changed since.
- Cost = price at the entry filing date. Re-entered positions show the most recent open lot.
- Options, ADRs, and unmapped CUSIPs are excluded from the follower-backtest pipeline that produces these snapshots, so certain holding types won't appear here.